TY - JOUR
T1 - Breast cancer screening initiation after turning 40 years of age within the PROSPR consortium
AU - Beaber, Elisabeth F.
AU - Tosteson, Anna N A
AU - Haas, Jennifer S.
AU - Onega, Tracy
AU - Sprague, Brian L.
AU - Weaver, Donald L.
AU - McCarthy, Anne Marie
AU - Doubeni, Chyke A.
AU - Quinn, Virginia P.
AU - Skinner, Celette Sugg
AU - Zauber, Ann G.
AU - Barlow, William E.
N1 - Publisher Copyright:
© 2016, Springer Science+Business Media New York.
PY - 2016/11/1
Y1 - 2016/11/1
N2 - Purpose: Although United States clinical guidelines differ, the earliest recommended age for average risk breast cancer screening is 40 years. Little is known about factors influencing screening initiation. Methods: We conducted a cohort study within the National Cancer Institute-funded Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) consortium. We identified 3413 women on their 40th birthday in primary care networks at Geisel School of Medicine at Dartmouth (DH) and Brigham and Women’s Hospital (BWH) during 2011–2013 with no prior breast imaging or breast cancer. Cumulative incidence curves and Cox modeling were used to determine time from the 40th birthday to first breast cancer screening, cohort exit, or 42nd birthday. We calculated hazards ratios and 95 % confidence intervals from multivariable Cox proportional hazards models. Results: Breast cancer screening cumulative incidence by the 42nd birthday was 62.9 % (BWH) and 39.8 % (DH). Factors associated with screening initiation were: a primary care visit within a year (HR 4.99, 95 % CI 4.23–5.89), an increasing number of primary care visits within a year (p for trend <0.0001), ZIP code of residence annual median household income ≤$52,000 (HR 0.79, 95 % CI 0.68–0.92), and health insurance type (Medicaid HR 0.72, 95 % CI 0.58–0.88; Medicare HR 0.55, 95 % CI 0.39–0.77; uninsured HR 0.37, 95 % CI 0.25–0.57). Conclusions: Breast cancer screening uptake after the 40th birthday varies by health system, primary care visits, median household income, and health insurance type, suggesting the need for further exploration. Future research should evaluate screening performance metrics after initiation and consider cumulative benefits and risks associated with breast cancer screening over time.
AB - Purpose: Although United States clinical guidelines differ, the earliest recommended age for average risk breast cancer screening is 40 years. Little is known about factors influencing screening initiation. Methods: We conducted a cohort study within the National Cancer Institute-funded Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) consortium. We identified 3413 women on their 40th birthday in primary care networks at Geisel School of Medicine at Dartmouth (DH) and Brigham and Women’s Hospital (BWH) during 2011–2013 with no prior breast imaging or breast cancer. Cumulative incidence curves and Cox modeling were used to determine time from the 40th birthday to first breast cancer screening, cohort exit, or 42nd birthday. We calculated hazards ratios and 95 % confidence intervals from multivariable Cox proportional hazards models. Results: Breast cancer screening cumulative incidence by the 42nd birthday was 62.9 % (BWH) and 39.8 % (DH). Factors associated with screening initiation were: a primary care visit within a year (HR 4.99, 95 % CI 4.23–5.89), an increasing number of primary care visits within a year (p for trend <0.0001), ZIP code of residence annual median household income ≤$52,000 (HR 0.79, 95 % CI 0.68–0.92), and health insurance type (Medicaid HR 0.72, 95 % CI 0.58–0.88; Medicare HR 0.55, 95 % CI 0.39–0.77; uninsured HR 0.37, 95 % CI 0.25–0.57). Conclusions: Breast cancer screening uptake after the 40th birthday varies by health system, primary care visits, median household income, and health insurance type, suggesting the need for further exploration. Future research should evaluate screening performance metrics after initiation and consider cumulative benefits and risks associated with breast cancer screening over time.
KW - Breast neoplasms
KW - Early detection of cancer
KW - Mammography
KW - Mass screening
KW - Prevention & control
KW - Primary health care
UR - http://www.scopus.com/inward/record.url?scp=84991389297&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84991389297&partnerID=8YFLogxK
U2 - 10.1007/s10549-016-3990-x
DO - 10.1007/s10549-016-3990-x
M3 - Article
C2 - 27665586
AN - SCOPUS:84991389297
SN - 0167-6806
VL - 160
SP - 323
EP - 331
JO - Breast Cancer Research and Treatment
JF - Breast Cancer Research and Treatment
IS - 2
ER -